ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2023 Earnings Call Transcript
ProPhase Labs, Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $-0.27.
Prophase Labs Inc. (PRPH)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 245,710 | $1,111,000 | -14% | 0% |
| 2. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | ||
| 4. | 0 | $0 | 0% | ||
| 5. | Winton Capital Management David Harding | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.48 | 721 | Director | 30,962 | 2022-03-10 | Filing | |
| $6.48 | 750 | Director | 30,991 | 2022-03-10 | Filing | |
| $5.07 | 33,943 | Large Shareholder, Officer, Director | 2,333,471 | 2021-06-03 | Filing | |
| $2.75 | 50,000 | Director | 273,840 | 2020-08-13 | Filing | |
| $1.75 | 100,000 | Director | 209,894 | 2020-03-26 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.75 | 50,000 | Large Shareholder, Officer, Director | 2,419,528 | 2020-08-13 | Filing | |
| $1.75 | 100,000 | Large Shareholder, Officer, Director | 2,549,528 | 2020-03-26 | Filing | |
| $2.30 | 424,789 | Large Shareholder, Officer, Director | 2,484,849 | 2017-12-21 | Filing | |
| $2.30 | 1,695,305 | Large Shareholder | 627,322 | 2017-09-29 | Filing | |
| $2.30 | 4,379 | Director | 7,721 | 2017-09-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 609,347 | $2,754,249 | 0% | |
| 2. | 173,124 | $782,000 | 0% | |
| 3. | 137,409 | $621,226 | 0% | |
| 4. | 85,900 | $388,268 | 0.21% | |
| 5. | 60,754 | $274,608 | 0% |
News See All
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2023 Earnings Call Transcript
Operator: Good day and welcome the ProPhase Labs Incorporated Third Quarter 2023 Financial Results and Corporate Update. All participants will be in listen-only mode.
ProPhase Labs, Inc. (NASDAQ:PRPH) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the ProPhase Labs Second Quarter 2023 Financial Results and Corporate Update. All participants’ will be in a listen-only mode.
ProPhase Labs, Inc. (NASDAQ:PRPH) Q1 2023 Earnings Call Transcript
Operator: Good day, and welcome to the ProPhase Labs Inc. First Quarter 2023 Financial Results and Corporate Update Conference Call.
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2022 Earnings Call Transcript
Operator: Hello and welcome to the ProPhase Labs Financial Results for the Year Ended December 31, 2022 Conference Call. Please note this event is being recorded.
ProPhase Labs, Inc. (NASDAQ:PRPH) Q3 2022 Earnings Call Transcript
Operator: Good morning, afternoon, evening, and welcome to the ProPhase Labs Third Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mode.
These 10 Stocks are Gaining After Announcing Share Buybacks
In this article, we discuss 10 stocks that are gaining after announcing share buybacks.
Is ProPhase Labs Inc (PRPH) A Good Stock To Buy Now?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Billionaire Hedge Funds
